HemoBioTech, Inc. Announces New Patent for Treating Acute Blood Loss
7/28/2010 8:58:58 AM
More...
|
HemoBioTech, Inc. and Its Innovative Blood Substitute HemoTech Could Benefit From House Resolution to Support Small Biotechnology Companies
3/25/2010 11:10:26 AM
More...
|
HemoBioTech, Inc. Gains Congressional Recognition of Its Blood Substitute Technology
8/17/2009 9:43:30 AM
More...
|
HemoBioTech, Inc. to Present "Need for Blood Substitute to Prevent HIV Transmission" at 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
6/2/2009 10:35:50 AM
More...
|
HemoBioTech, Inc. to Present Blood Substitute Strategy at RENN Capital Investor Conference
5/15/2009 10:20:59 AM
More...
|
HemoBioTech, Inc. Addition of Dr. Roscoe M. Moore Jr. Former US Assistant Surgeon General to Scientific Advisory Board
3/12/2009 9:11:48 AM
More...
|
HemoBioTech, Inc. Announces Dramatic Clearance of Prions with the ORTH Technology
3/10/2009 9:34:39 AM
More...
|
HemoBioTech, Inc. Announces Publication of a Guest Editorial and Two Review Articles on Blood Substitutes by Dr. Jan Simoni – Co-Inventor of HemoTech
2/26/2009 9:52:26 AM
More...
|
HemoBioTech, Inc. to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
11/11/2008 9:22:58 AM
More...
|
HemoBioTech, Inc. Chairman & CEO Arthur Bollon, Ph.D., to Present at the Biotechnology Industry Organization (BIO) International Convention in San Diego, CA
6/18/2008 9:44:27 AM
More...
|
|